What top creators are saying about Bright Minds Biosciences Inc.(DRUG)
Biotechnology company developing treatments for neurological and psychiatric disorders.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Bright Minds Biosciences Inc..
Top creators covering Bright Minds Biosciences Inc. (DRUG)
The 1 sources with the most insights about Bright Minds Biosciences Inc. on Kazuha.
Latest insights about Bright Minds Biosciences Inc. (DRUG)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
The stock fell sharply after a clinical hold on the EMB-101 program. Both regulatory resolution and the drug's commercial prospects remain uncertain.
Yesterday
The stock fell sharply after a clinical hold on the EMB-101 program. Both regulatory resolution and the drug's commercial prospects remain uncertain.
Discussed alongside Bright Minds Biosciences Inc. (DRUG)
Other assets that creators frequently mention in the same content as Bright Minds Biosciences Inc..
Frequently asked
Which podcasters and creators cover Bright Minds Biosciences Inc. (DRUG) the most?
The most active sources covering Bright Minds Biosciences Inc. (DRUG) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Bright Minds Biosciences Inc. (DRUG) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Bright Minds Biosciences Inc. (DRUG) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Bright Minds Biosciences Inc. (DRUG)?
Creators covering Bright Minds Biosciences Inc. (DRUG) most frequently also discuss INTC, LRCX, MRVL, V, MCO. See the "Discussed alongside" section above for full asset pages.